Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo
Umeå life science company granted millions to develop new product
Finance

Umeå life science company granted millions to develop new product

Umeå Biotech Incubator
April 5, 2019

Life science company Inficure Bio has been awarded millions by Vinnova to support the company's development of a model that will help create new treatments for fibrosis.

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2018
Finance

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2018

InDex Pharmaceuticals
April 4, 2019

April 2, 2019 – InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2018, which is earlier than indicated in the financial calendar. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website, www.indexpharma.com.

MVA-member, Ascelia Pharma, publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm
Finance

MVA-member, Ascelia Pharma, publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm

Medicon Valley Alliance
February 25, 2019

MVA-member, Ascelia Pharma, publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm

InDex Pharmaceuticals Holding AB (publ) year end report 2018
Finance

InDex Pharmaceuticals Holding AB (publ) year end report 2018

InDex Pharmaceuticals
February 21, 2019

Continued focus on the patient recruitment for the CONDUCT study

Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
Finance

Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018

Novo Nordisk Pharmatech A/S
February 4, 2019

Operating profit increased by 6% measured in local currencies when adjusted for the cost of severance and the priority review voucher for oral semaglutide

Ten new incubator companies and over SEK 700 million in venture capital
Finance

Ten new incubator companies and over SEK 700 million in venture capital

SmiLe Incubator
January 31, 2019

In 2018 SmiLe met its annual goal of finding about ten new life science startup companies with a strong team, a high level of innovation and strong international market potential. SmiLe has thereby helped a total of 70 companies to develop their products for better health, including the current 22 member companies. Together, they have attracted a record amount of SEK 728 million in venture capital, 18 percent more than the previous year’s high figure.

Date
Title
Author
November 26, 2018
SAGA awarded SEK 4.7 million Vinnova grant from Swelife
SmiLe Incubator
November 26, 2018
Sinntaxis secures Horizon 2020 grant to prepare for phase II trial in stroke recovery
SmiLe Incubator
November 20, 2018
AbbVie Donates $55 Million to Three Education Nonprofits Supporting Underserved Youth in Chicago & Across America
AbbVie
November 15, 2018
Swedish Research Council gives In2cure project SEK 950,000 and highest grades
SmiLe Incubator
November 7, 2018
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2019 Annual General Meeting
InDex Pharmaceuticals
October 25, 2018
InDex Pharmaceuticals carries out a directed share issue of approximately SEK 37.5 million
InDex Pharmaceuticals
October 2, 2018
in2cure raises SEK 10 million
SmiLe Incubator
September 25, 2018
Curida attracts new investors
Curida AS
August 23, 2018
In need of start-up money?
Oslo Cancer Cluster
August 9, 2018
Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018
Novo Nordisk Pharmatech A/S
May 2, 2018
AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock
AbbVie
May 2, 2018
AbbVie Reports First-Quarter 2018 Financial Results
AbbVie
April 26, 2018
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2017
InDex Pharmaceuticals
April 26, 2018
InDex Pharmaceuticals Holding AB – Annual Report 2017
InDex Pharmaceuticals

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019